title: Patient information leaflets--helpful guidance or a source of confusion?
abstract: BACKGROUND
  According to the European Community Directive 92/27, pharmaceutical companies are responsible for working out patient information leaflets (PILs) for all products marketed, and every PIL should comply with the Summary of Product Characteristics (SPC) and be phrased so that it is easily understandable by the patient. However, the volume of information included in the PIL may differ for different brands, and furthermore, the same drug may be registered for different indications. Patients may therefore receive different drug information when they renew prescriptions for the same generic drug.
  
  
  OBJECTIVE
  To examine if PILs on different brands of generically identical drugs contain inconsistent and diverging information that may lead to confusion.
  
  
  METHODS
  Case-finding among patients who contacted a pharmacy because of problems related to the information retrieved from the PIL.
  
  
  METHODS
  Inquiries to a Danish pharmacy during one year (1 June 2000-31 May 2001).
  
  
  RESULTS
  Different brands of generically identical products included PILs with substantial inconsistencies. Diverging information about indications for drug use, adverse effects, drug-drug interactions and precautions and considerations concerning pregnancy and breastfeeding resulted in inquiries to the pharmacy.
  
  
  CONCLUSIONS
  Patients may be confused by inconsistent information in PILs from different brands of generically identical drugs. Confusion about drug treatment may lead to reduced compliance and initiatives should be taken to coordinate information in PILs covering the same generic product.
authors.affiliation: Research Unit of General Practice, University of Southern Denmark, DK-5000 Odense, Denmark. lbjerrum@health.sdu.dk
authors.forename: Lars
authors.initials: L
authors.lastname: Bjerrum
authors.forename: Annette
authors.initials: A
authors.lastname: Foged
mesh_terms: D003157:Community Pharmacy Services; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards; D004346:Drug Information Services / Q000331:legislation & jurisprudence / Q000592:standards*; D004347:Drug Interactions; D004348:Drug Labeling / Q000592:standards; D011307:Drug Prescriptions; D016568:Drugs, Generic; D010174:Pamphlets; D010353:Patient Education as Topic / Q000592:standards*
chemical_list: D016568:Drugs, Generic